Synthesis and antiviral activity of certain 5'-modified analogs of 2,5,6-trichloro-1-(β-D-ribofuranosyl)benzimidazole

Journal of Medicinal Chemistry

Volumn 40, Issue 5, 1997, Pages 785-793

  Gudmundsson, Kristjan S ^a   Drach, John C ^b   Wotring, Linda L ^b   Townsend, Leroy B ^b  

^a Tanabe Research Laboratories   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BENZIMIDAZOLE DERIVATIVE; RIBONUCLEOSIDE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION; VIRUS INFECTION;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; BENZIMIDAZOLES; CELL DIVISION; CELLS, CULTURED; CYTOMEGALOVIRUS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MOLECULAR STRUCTURE; RIBONUCLEOSIDES; SIMPLEXVIRUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031052117     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9604888     Document Type: Article

References (45)

1. (a) Krech, U.; Jung, M.; Jung, F. Cytomegalovirus Infections of Man; S. Karger Publishers: New York, 1971; pp 19-32.
2. (b) Alford, C. A.; Britt, W. J. Cytomegalovirus. In The Human Cytomegalovirus, Roizman, B., Whitley, R. J., Lopez, C., Eds.; Raven Press: New York, 1993; pp 227-255.
3. Wingard, J. R.; Piantadosi, S.; Burns, W. H.; Zahurak, M. L.; Santos, G. W.; Saral, R. Cytomegalovirus Infections in Bone Marrow Transplant Recipients Given Intensive Cytoreductive Therapy. Rev. Infect. Dis. 1990, 12, S793-S804.
4. (a) McKenzie, R.; Travis, W. D.; Dolan, S. A.; Pittaluga, S.; Feuerstein, I. M.; Shelhamer, J.; Yarchoan, R.; Masur, H. The Cause of Death in Patients with Human Immunodeficiency Virus Infection: A Clinical and Pathological Study with Emphasis on the Role of Pulmonary Diseases. Medicine 1991, 70, 326-343.
5. (b) Vinters, H. V.; Kwok, M. K.; Ho, H. W. Cytomegalovirus in the Nervous System of Patients with the Acquired Immune Deficiency Syndrome. Brain 1989, 112, 245-268.
6. Britt, W. J.; Pass, R. F.; Stagno, S.; Alford, C. A. Pediatric Cytomegalovirus Infection. Transplant. Proc. 1991, 23, 115-117.
7. Faulds, D.; Heel, R. C. Ganciclovir: A Review of its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Efficacy in Cytomegalovirus Infections. Drugs 1990, 39, 597-638.
8. Chrisp, P.; Clissold, S. P. Foscarnet. A Review of its Antiviral Activity, Pharmacokinetic Properties and Therapeutic use in Immunocompromised Patients with Cytomegalovirus Retinitis. Drugs 1991, 41, 104-129.
9. (a) Bronson, J. J.; Ghazzouli, I.; Hitchcock, M. J. M.; Webb, R. R.; Martin, J. C. Synthesis and Antiviral Activity of the Nucleotide Analogue (S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]-cytosine. J. Med. Chem. 1989, 32, 1457-1463.
10. (b) Lalezari, J. P.; Drew, W. L.; Glutzer, E.; James, C.; Miner, D.; Flaherty, J.; Fisher, P. E.; Cundy, K.; Hannigan, J.; Martin, J. C.; Jaffe, H. S. (S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine (Cidofovir): Results of a Phase I/II Study of a Novel Antiviral Nucleotide Analogue. J. Infect. Dis. 1995, 171, 788-796.
11. Field, A. K.; Biron, K. K. "The End of Innocence" Revisited: Resistance to Antiviral Drugs. Clin. Microbiol. Rev. 1994, 7, 1-13.
12. (a) Revankar, G. R.; Townsend, L. B. Benzimidazole Nucleosides, Nucleotides, and Related Derivatives. Chem. Rev. 1970, 70, 389-438.
13. (b) Revankar, G. R.; Townsend, L. B. The Synthesis of 2-Chloro-1-(β-D-ribofuranosyl)benzimidazole and Certain Related Derivatives. J. Heterocycl. Chem. 1968, 5, 477-483.
14. (a) Devivar, R. V.; Drach J. C.; Townsend, L. B. Benzimidazole Ribonucleosides: Observation of an Unexpected Nitration when Performing Nonaqueous Diazotizations with t-Butyl Nitrate. Bioorg. Med. Chem. Lett. 1992, 2, 1105-1110.
15. (b) Devivar, R. V.; Kawashima, E.; Revankar, G. R.; Breitenbach, J. M.; Kreske, E. D.; Drach, J. C.; Townsend, L. B. Benzimidazole Ribonucleosides: Design, Synthesis and Antiviral Activity of Certain 2-(Alkylthio)- and 2-(Benzylthio)-5,6-dichloro-1-(β-D-ribofuranosyl)benzimidazoles. J. Med. Chem. 1994, 37, 2942-2949.
16. Townsend, L. B.; Devivar, R. V.; Turk, S. R.; Nassiri, M. R.; Drach, J. C. Design, Synthesis and Antiviral Activity of Certain 2,5,6-Trihalo-1-(β-D-ribofuranosyl)benzimidazoles. J. Med. Chem. 1995, 38, 4098-4105.
17. (a) Turk, S. R.; Black, J. M.; Borysko, K. Z.; Edwards, C. A.; Nassiri, M. R.; Townsend, L. B.; Drach, J. C. Benzimidazole Ribonucleosides: Mode of Action of TCRB in HCMV-Infected Cells. Fifth International Conference on Antiviral Research, Vancouver, British Columbia, Canada, March 1992.
18. (b) Drach, J. C.; Townsend, L. B.; Nassiri, M. R.; Turk, S. R.; Coleman, L. A.; Devivar, R. V.; Genzlinger, G.; Kreske, E. D.; Renau, T. E.; Westerman, A. C.; Shipman, C., Jr.; Biron, K. K.; Dornsife, R.; Kern, E. R. Benzimidazole Ribonucleosides: A New Class of Antivirals with Potent and Selective Activity Against Human Cytomegalovirus. Fifth International Conference on Antiviral Research, Vancouver, British Columbia, Canada, March 1992.
19. (a) Underwood, M. R.; Biron, K. K.; Hemphill, M. L.; Miller, T. J.; Stanat, S. C.; Drach, J. C.; Townsend, L. B.; Harvey, R. J. The Benzimidazole Riboside, 2-Bromo-5,6-dichloro-1-β-D-ribofuranosyl Benzimidazole (BDCRB), Prevents Maturation of Concatemeric Viral DNA in HCMV-Infected Cells. 4th International CMV Conference, Institut Pasteur, Paris, France, April 1993.
20. (b) Underwood, M. R.; Biron, K. K.; Hemphill, M. L.; Stanat, S. C.; Dornsife, R. E.; Drach, J. C.; Townsend, L. B.; Edwards, C. A.; Harvey, R. J. High Molecular Weight HCMV DNA does not Properly Mature in Presence of 2-Bromo-5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (BDCRB). Herpesvirus Workshop, Pittsburgh, PA, July 1993.
21. (c) Underwood, M. R.; Stanat, S. C.; Drach, J. C.; Harvey, R. J.; Biron, K. K. Inhibition of HCMV DNA Processing by a New Class of Anti-HCMV Compounds is Mediated Through the UL89 Gene Product. Herpesvirus Workshop, Vancouver, British Columbia, Canada, August 1994.
22. (d) Underwood, M. R.; Stanat, S. C.; Townsend, L. B.; Drach, J. C.; Biron, K. K. Inhibition of HCMV DNA Processing by a New Class of Anti-HCMV Compounds (Benzimidazole Ribosides) is Mediated through the UL89 Gene Product. 8th International Conference on Antiviral Research, Santa Fe, NM, April 1995.
23. Saluja, S.; Zou, R.; Drach, J. C.; Townsend, L. B. Structure Activity Relationships Among 2-Substituted 5,6-Dichloro-, 4,6-Dichloro-, and 4,5-Dichloro-1-(2-hydroxyethoxymethyl)- and 1-[(1,3-dihydroxy-2-propoxy)methyl]benzimidazoles. J. Med. Chem. 1996, 39, 881-892.
24. Holy, A.; Konig, J.; Vesely, J.; Cech, D.; Votruba, I.; De Clercq, E. 5′-O-Alkyl-5-fluorouridines: Synthesis and Biological Activities. Collect. Czech. Chem. Commun. 1987, 52, 1589-1608.
25. Vorbruggen, H.; Hofle, G. On the Mechanism of Nucleoside Synthesis. Chem. Ber. 1981, 114, 1256-1268.
26. Hanessian, S.; Kagotani, M.; Komaglou, K. Design and Reactivity of Organic Functional Groups- 2-Pyridylsulfonates as Nucleofugal Esters: Remarkably Mild Transformation into Halides and Olefins. Heterocycles 1989, 28, 1115-1120.
27. Kissman, H. M.; Weiss, M. J. 5-Deoxy-5-fluoro-D-ribofuranosyl Derivatives of Certain Purines, Pyrimidines and 5,6-Dimethyl-benzimidazole. J. Chem. Soc. 1958, 80, 5559-5564.
28. Classon, B.; Liu, Z. New Halogenation Reagent Systems Useful for the Mild One-Step Conversion of Alcohols into Iodides or Bromides. J. Org. Chem. 1988, 53, 6126-6130.
29. Kissman, H. M.; Baker, B. R. The Synthesis of Certain 5-Deoxy-D-ribofuranosylpurines. J. Am. Chem. Soc. 1957, 79, 5534-5540.
30. Kanazawa, T.; Sato, T. D-Ribose Derivatives. II. Preperation of 2,3-Di-O-acetyl-5-deoxy-5-iodoribofuranosyl Chloride from 5-O-Triphenylmethyl-D-ribose. Nippon Kagaku Zasshi 1059, 80, 200-203.
31. Browne, C. E.; Ugarkar, B. G.; Mullane, K. M.; Gruber, H. E.; Bullough, D. A.; Erion, M. A. Adenosine Kinase Inhibitors. Eur. Pat. Appl. EP 496,617, Cl CO7H19/16, July 29, 1992.
32. Pearson, W. H.; Bergmeier, S. C. A Synthesis of (-)-Slaframine and (-)-1,8a-Diepislaframine. J. Org. Chem. 1991, 56, 1976-1978.
33. Mitsunobo, O. The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products. Synthesis 1981, 1-28.
34. (a) Montgomery, J. A.; Shortnacy, A. T.; Thomas, H. J. Analogs of 5′-Deoxy-5′-(methylthio)adenosine. J. Med. Chem. 1974, 17, 1197-1209.
35. (b) Kanazawa, T. A New Synthesis of 9-β-(5′-thiomethyl-D-ribofuranosyl)adenine. Nippon Kagaku Zasshi 1960, 81, 516-517.
36. Baker, B. R. In Ciba Foundation Symposium on the Chemistry and Biology of the Purines; Wolstenholme, G. E., O'Connors, C. M., Eds.; Little, Brown and Co.: Boston, 1957; p 120.
37. Drach, J. C.; Bush, P. M.; Ptak, R. G.; Devivar, R. V.; Townsend, L. B.; Davis, M. G.; Underwood, M. R.; Biron, K. K. Halogenated Benzimidazole 5′-Deoxyribonucleosides are Potent and Selective Inhibitors of Human Cytomegalovirus Replication. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 1995.
38. Still, W. C.; Kahn, M.; Mitra, A. Rapid Chromatographic Techniques for Preparative Separation with Moderate Resolution. J. Org. Chem. 1978, 43, 2923-2925.
39. Perrin, D. D.; Armarego, W. L. F. Purification of Laboratory Chemicals, 3rd Ed.; Pergamon Press: New York, 1988.
40. Shipman, C., Jr.; Smith, S. H.; Carlson, R. H.; Drach, J. C. Antiviral Activity of Arabinofuranosyladenine and Arabinofuranosylhypoxanthine in Herpes Simplex Virus-Infected KB Cells. I. Selective Inhibition of Viral DNA Synthesis in Synchronized Suspension Cultures. Antimicrob. Agents Chemother. 1976, 9, 120-127.
41. Turk, S. R.; Shipman, C., Jr.; Nassiri, M. R.; Genzingler, G.; Krawczyk, S. H.; Townsend, L. B.; Drach, J. C. Pyrrolo[2,3-d]-pyrimidine Nucleosides as Inhibitors of Human Cytomegalovirus. Antimicrob. Agents Chemother. 1987, 31, 544-550.
42. Prichard, M. N.; Turk, S. R.; Coleman, L. A.; Engelhardt, S. L.; Shipman, C., Jr.; Drach, J. C. A Microtiter Virus Yield Reduction Assay for the Evaluation of Antiviral Compounds Against Human Cytomegalovirus and Herpes Simplex Virus. J. Virol. Methods 1990, 28, 101-106
43. Prichard, M. N.; Shipman, C., Jr. A Three Dimensional Model to Analyze Drug-Drug Interactions. Antiviral Res. 1990, 14, 181-206.
44. Prichard, M. N.; Prichard, L. E.; Baguley, W. A.; Nassiri, M. R.; Shipman, C., Jr. Three-Dimensional Analysis of the Synergistic Cytotoxicity of Ganciclovir and Zidovudine. Antiviral Res. 1991, 35, 1060-1065.
45. Cory, A. H.; Owen, T. C.; Barltrop, J. A.; Cory, J. G. Use of an Aqueous Soluble Tetrazolium/Formazan Assay for Cell Growth Assays in Culture. Cancer Commun. 1991, 3, 207-212.